The National Institutes of Health have launched a placebo-controlled trial testing the safety and efficacy of hydroxychloroquine and azithromycin as a treatment for COVID-19.
The National Institutes of Health has begun a clinical trial testing the effectiveness of combining antimalarial drug hydroxychloroquine with antibiotic azithromycin as a treatment for COVID-19.
The trial is being sponsored by the NIH's National Institute of Allergy and Infectious Diseases . White House coronavirus task force member and NIAID Director Dr. Anthony Fauci said that rigorous trials of existing drugs need to be conducted to find one that may help slow the rising COVID-19 death toll.
日本 最新ニュース, 日本 見出し
Similar News:他のニュース ソースから収集した、これに似たニュース記事を読むこともできます。
Convalescent plasma is safe to treat COVID-19: nationwide studyThe experimental therapy involves transfusing the antibody-rich blood serum of recovered COVID-19 patients into people who are battling the coronavirus.
続きを読む »
Trump admin to ramp up syringe production for future COVID-19 vaccineThe Trump admin. unveils a plan to dramatically increase production of specialized syringes to be used for a future COVID-19 vaccine.
続きを読む »
Can sport survive the covid-19 pandemic without spectators?Even without live spectators, staging professional sport amid the pandemic is far from risk-free
続きを読む »
Canceled Gigs, Postponed Surgery: How COVID-19 Upended One Indie Artist's Year“Playing shows is probably 90 percent of my income,” says Kristin Hayter, who performs as Lingua Ignota. What happens when that’s not an option?
続きを読む »
Why Purpose-Driven Businesses Are Faring Better In Covid-19Purpose-driven businesses are more resilient, thanks to the motivating effect of working toward something larger than profit or growth for its own sake. All companies can harness their potential impact to innovate and collaborate in more effective and human ways.
続きを読む »